Skip to content
Advancing Generic Drug Development (AGDD): Modernizing Bioequivalence Approaches for Topical & Transdermal Products Banner

Advancing Generic Drug Development:
Modernizing Bioequivalence Approaches for 
Topical & Transdermal Products
September 10, 2026

Click Here for Details

PDF Download
Event Agenda

The event agenda is still being refined and may be updated over time. The current version is v4, uploaded on August 4, 2026.

PDF Download
Speaker Biographies

The speaker biographies document provides detailed information for each of the event presenters.  The speaker biographies document is still being refined and may be updated over time.

Continuing Education

This event has been pre-approved by:

  • RAPS as eligible for a maximum of 12 credits for a two-day event (appropriate to real-time attendance) towards a participant’s RAC recertification upon full completion.
  • SOCRA who accepts documentation of candidate participation in continuing education programs for re-certification if the program is applicable to clinical research regulations, operations or management, or to the candidate’s clinical research therapeutic area.
  • SQA as eligible for 1 non-GCP or non-GLP unit for every 1 hour of instructional time towards a participant’s RQAP re-registration.
  • ACRP for continuing education in clinical research. ACRP will provide 1 ACRP contact hour for every 45-60 minutes of qualified material.

Questions?

Please refer the FAQs page on this website. If you are not able to find your answer there, please email us at info@sbiaevents.com.

If you have questions regarding the content of the event or other CDER-specific information, please: